皮皮学,免费搜题
登录
搜题
【单选题】
For years, doctors have given cancer patients three main treatments: surgery, radiation and chemotherapy. Now researchers are developing a fourth weapon: the patient's own immune system. New vaccines and drugs can stimulate the production of an army of cells and antibodies that kill cancer cells. Drug-vaccine therapy may lie lifesaver for Deerfield man. Few people survive advanced melanoma, but immune therapy is giving Deerfield resident Douglas Parker a fighting chance. The 46-year-old salesman noticed a mole on his chest three and a half years ago that was found to be cancerous. Doctors removed the mole but didn't get all of the cancer. The cancer spread to other parts of his body, including his liver, where a tumor grew as large as a baseball. Parker took interferon and interleukin-2 to boost his immune system's ability to fight the cancer. The tumor shrank but didn't disappear. In August, 1997, surgeons removed it, along with two thirds of his liver. Last January, doctors discovered a new tumor on Parker's left adrenal gland. He received an experimental cancer vaccine at the University of Chicago Hospitals, but the vaccine didn't stop the cancer from spreading to his right adrenal gland. To augment the vaccine, doctors at Lutheran General Hospital gave Parker a new round of intcrleukin-2 and interferon. The drug-vaccine combination has shrunk the tumors. And while it's too early to pronounce Parker cured, immune therapy may save his life. 'I want to do this to help myself as well as other people who have melanoma,' he said. Immune therapy 'ultimately will be a significant change in the way we treat a lot of different cancers,' said Dr. Jon Richards of Lutheran General Hospital in Park Ridge, who is testing cancer vaccines on melanoma patients. 'It will be an equal partner with the other three treatments in the next five to ten years.' Several drugs that bolster the immune system have been approved, and vaccines are being tested in dozens of clinical trials, including several in the Chicago area. Many of the experimental vaccines have been tested on patients with advanced melanoma who have little chance of surviving with conventional treatments alone. Researchers also have begun doing work that could lead to vaccines to treat prostate, lung, colon and other cancers. Immune therapy alone won't cure cancer. But when used after conventional treatments, it could kill cancer cells that survive surgery, radiation or chemotherapy, researchers said. Some day, vaccines also might be able to prevent certain cancers. It may be possible to vaccinate against viruses and bacteria that help cause cervical, liver and stomach cancers, the National Cancer Institute said. The 'fourth weapon' cures cancer by ______.
A.
replacing cancerous cells
B.
boosting the immune system
C.
killing cancer cells directly
D.
quickening the reproduction of cells
拍照语音搜题,微信中搜索"皮皮学"使用
参考答案:
参考解析:
知识点:
.
..
皮皮学刷刷变学霸
举一反三
【判断题】单位IP地址范围内的用户只能通过判断IP自动登录获取相应访问权限。
A.
正确
B.
错误
【单选题】安全技术防范系统三要素之间的关系为( )。
A.
T探测+ T反应> T延迟
B.
T探测+ T反应
C.
T探测+ T延迟
D.
T反应+ T延迟
【单选题】下面哪个系统预定义角色允许一个用户创建其他用户? ()
A.
CONNECT
B.
DBA
C.
RESOURCE
D.
SYSDBA
【单选题】26岁初产妇,产钳助娩一3600g女婴,现产后1小时,在产房观察。该产妇产后第4天发热,双乳胀痛,检查体温38.2℃,双乳红肿,血管淋巴充盈,有硬结,此时最可能的诊断为()
A.
乳腺炎
B.
上呼吸道感染
C.
子宫内膜炎
D.
乳汁淤积
E.
会阴伤口感染
【单选题】安全防范系统三要素之间的关系可以用 公式进行概括。
A.
T反应≥T探测十T延迟
B.
T反应十T探测≥T延迟
C.
T反应十T探测≤T延迟
【单选题】T表示时间,安全技术防范系统三要素之间的关系为()。
A.
T探测+T反应=T延迟
B.
T探测+T反应
C.
T探测+T延迟
D.
T反应+T延迟
【单选题】安全技术防范系统三要素之间的关系为( )。
A.
T探测+ T反应> T延迟
B.
T探测+ T反应< T延迟
C.
T探测+ T延迟< T反应
D.
T反应+ T延迟 < T探测
【单选题】25岁初产妇,产钳助娩一3500g女婴,现产后1小时,在产房观察。该产妇产后第4天发热,双乳胀痛,检查体温38.2℃,双乳红肿,血管淋巴充盈,有硬结,此时最可能的诊断为()
A.
会阴伤口感染
B.
上呼吸道感染
C.
子宫内膜炎
D.
乳汁淤积
E.
乳腺炎
【多选题】患儿,男,10个月,因发热4天入院,体温最高40℃,无咳嗽、流涕、咽痛等上呼吸道感染症状,无呕吐、腹痛及腹泻,查体:热病容,神萎,皮肤黏膜未见皮疹及出血点,右颈部可触及1个花生粒大小淋巴结,质软,无粘连及触痛,结膜无充血,口唇鲜红、干裂,口腔黏膜弥漫性充血,双扁桃体Ⅱ度肿大,无脓苔,心肺腹查体未见明显异常。门诊以。呼吸道感染"收入院。提示:病程3周,患儿随访心脏B超发现左冠状动脉主干内径为4mm,...
A.
静脉丙种球蛋白1~2g/kg,再次输入
B.
加强抗凝治疗
C.
抗生素治疗
D.
激素
E.
溶栓治疗
F.
果糖保心治疗
【简答题】心理实验程序设计的四种模式分别是( ), ( ), ( ), ( )。
相关题目: